According to Future Market Insights, the Testosterone Injectable Market is expected to grow at a 4.1% CAGR between 2021 and 2031. One of the most important classes of hormone injectable therapy used globally is testosterone injectable therapy.
Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14052
Because of increased awareness about the benefits and efficacy of testosterone replacement therapy products, the testosterone injectable market is gaining acceptance among patients and physicians.
Testosterone is the primary male hormone responsible for improving male sexual characteristics, spermatogenesis, and fertility. A lack of testosterone production causes erectile dysfunction, which can be treated with testosterone injections.
What is Driving Demand for Testosterone Injectable Market?
The rise in geriatric population with high risk of testosterone deficiency, growing awareness about testosterone injectable, improved health care infrastructure, policies, and advancement in health care infrastructure are all driving demand for testosterone injectables.
Furthermore, access to various diagnostic and treatment services has improved in recent years, particularly in developed economies, and this is one of the major factors driving demand for testosterone injectables.
Request Sample PDF Brochure:
https://www.futuremarketinsights.com/reports/brochure/rep-gb-14052
The U.S. Testosterone Injectable Market Outlook
Countries such as the United States dominate the testosterone injectable market. A study published in the European Association of Urology Journal found that testosterone treatment patterns in the United States have increased by 1.8 to 4-fold over the last two decades.
Furthermore, an increasing number of people suffering from hypogonadism, a growing geriatric population, and an increase in the availability of effective and convenient treatment options all contribute to an increase in demand for testosterone injectable in the United States. To meet the demand for testosterone injectables, the United States is making a number of efforts to strengthen its research and development facilities.
Europe Demand Outlook for Testosterone Injectable Market
According to a study published in the National Center for Biotechnology Information (NCBI), hypogonadism affects approximately 30% of men worldwide. Europe is known for its numerous medical centres, robust healthcare infrastructure, and growing government initiative.
Furthermore, rising testosterone deficiency incidence, an increase in the geriatric population at high risk of testosterone deficiency, and increased awareness about testosterone substitute therapy are the key driving factors in Europe’s testosterone injectable market.
Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-14052
Who are the Key Manufacturers and Suppliers of Testosterone Injectable Market?
The key companies working in testosterone injectable and solutions for testosterone injectable are
- Clarus Therapeutics
- Bayer AG
- Endo Pharmaceuticals Inc.
- Eli Lilly Company
- Kyowa Kirin International plc
- Mylan N.V.
- Novartis AG
- and Pfizer Inc.
- J & K Scientific Ltd.
- Beijing Coupling Technology Co.Ltd.
- Longyan Tianhua Biological Technology Co.Ltd
Manufacturers in the market concentrate on strategic activities such as acquisitions and mergers, expansion, product launch, and so on. For example, on May 25, 2020, Partner Perspectives announced the launch of JATENZO®, an oral softgel formulation of testosterone undecanoate (TU) for adult males with conditions associated with a deficiency or absence of endogenous testosterone.
The report is a compilation of first-hand information, qualitative and quantitative analysis by industry analysts, and input from industry experts and value chain participants. The report examines parent market trends, macroeconomic indicators, and governing factors, as well as market attractiveness by segment. The qualitative impact of various market factors on market segments and geographies is also depicted in the report.
Inquire Before Buying Research Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-14052
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs